SUZHOU,China,April 15,2025-- In January 2025 (U.S. time),the U.S. Food and Drug Administration (FDA) officially approved the Investigational New Drug (IND) application submitted by XellSmart Biopharma
RIYADH,Saudi Arabia,April 15,2025-- The second edition of the Human Capability Initiative (HCI),has concluded,hosting over 300 influential leaders,policymakers,and global experts from 40 countries,inc
BEIJING,April 16,2025-- Z.ai (formerly Zhipu) announces the open-sourcing of its 32B and 9B GLM model series,including base,reasoning,and rumination models,all under the MIT license. These models are
MELBOURNE,Australia and INDIANAPOLIS,April 16,2025-- Telix Pharmaceuticals Limited (ASX: TLX,NASDAQ: TLX,Telix,the Company) today announces preliminary results from the Phase 2 IPAX-Linz study of TLX
TAIPEI,April 16,2025-- FETC International (FETCi) and its parent company Far Eastern Electronic Toll Collection Co. (FETC),Ltd have received third-party verification for greenhouse gas (GHG) emission
Leverages Technology Building Blocks,Expands Motion-by-Wire Chassis Control AUBURN HILLS,Mich.,April 16,2025-- Nexteer Automotive launches its Electro-Mechanical Brake (EMB) system,an advanced Brake-
